It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Organoids generated from pluripotent stem cells are used in the development of organ replacement regenerative therapy by recapitulating the process of organogenesis. These processes are strictly regulated by morphogen signalling and transcriptional networks. However, the precise transcription factors involved in the organogenesis of exocrine glands, including salivary glands, remain unknown. Here, we identify a specific combination of two transcription factors (Sox9 and Foxc1) responsible for the differentiation of mouse embryonic stem cell-derived oral ectoderm into the salivary gland rudiment in an organoid culture system. Following orthotopic transplantation into mice whose salivary glands had been removed, the induced salivary gland rudiment not only showed a similar morphology and gene expression profile to those of the embryonic salivary gland rudiment of normal mice but also exhibited characteristics of mature salivary glands, including saliva secretion. This study suggests that exocrine glands can be induced from pluripotent stem cells for organ replacement regenerative therapy.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details










1 Division of Pathology, Department of Oral Diagnostic Sciences, School of Dentistry, Showa University, Tokyo, Japan
2 Laboratory for Organ Regeneration, RIKEN Center for Biosystems Dynamics Research (BDR), Kobe, Hyogo, Japan; Organ Technologies Inc., Tokyo, Japan
3 Clinical Biotechnology, Center for Disease Biology and Integrative Medicine, The University of Tokyo, Tokyo, Japan
4 Laboratory for Integrative Genomics, RIKEN IMS, Yokohama, Kanagawa, Japan
5 Department of Biochemistry and Biophysics, Graduate School of Health Care Sciences, Tokyo Medical and Dental University, Tokyo, Japan
6 Department of Molecular and Cellular Biochemistry, Osaka University Graduate School of Dentistry, Osaka, Japan
7 Department of Oral Physiology, School of Dentistry, Showa University, Tokyo, Japan
8 Department of Oral and Maxillofacial Surgery, School of Dentistry, Showa University, Tokyo, Japan
9 Division of Pathology, Department of Oral Diagnostic Sciences, School of Dentistry, Showa University, Tokyo, Japan; Division of Anatomical and Cellular Pathology, Department of Pathology, Iwate Medical University, Iwate, Japan
10 Division of Pathology, Department of Oral Diagnostic Sciences, School of Dentistry, Showa University, Tokyo, Japan; Laboratory for Integrative Genomics, RIKEN IMS, Yokohama, Kanagawa, Japan; Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima, Japan
11 Department of Oral-Facial Disorders, Osaka University Graduate School of Dentistry, Osaka, Japan
12 Laboratory for Integrative Genomics, RIKEN IMS, Yokohama, Kanagawa, Japan; Department of Technology Development, Kazusa DNA Research Institute, Chiba, Japan
13 Department of Pathology, Tsurumi University School of Dental Medicine, Yokohama, Kanagawa, Japan